medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 610

<< Back Next >>

Rev Med Cos Cen 2014; 71 (610)

Sindrome Guillain-Barre

Mairena SA, Mata EC, Calderón MD
Full text How to cite this article

Language: Spanish
References: 10
Page: 261-265
PDF size: 201.18 Kb.


Key words:

Guillain-Barré Syndrome, autoimmune, muscular weakness, myelin.

ABSTRACT

Guillain-Barre syndrome is an acute disorder, where the immune system attacks the peripheral nervous, destroying the axons’s myelin sheath of many peripheral nerves, this condition corresponds to an autoimmune disease process. It’s currently unknown exactly triggers this syndrome. The first symptoms of this disorder include varying degrees of weakness or numbness in the lower limbs, upper limbs, chest and abdomen. This disorder present a progress distal to proximal. A common consequence of this patology is the patient’s paralysis, because the muscles don’t respond to brain’s electrical impulses. It can even affect breathing, blood pressure and heart rate, becoming a medical emergency. However, the majority of patients recover, including the most severe cases of Guillain- Barre syndrome. The main object in this review is provide the reader, with necessary knowledge Guillain- Barre Syndrome’s diagnosis and initial patient’s management in a basic medical center, and efficient transfer to specialized medical center for treatment and support.


REFERENCES

  1. Acosta M, Cañizá M, Romano M. SINDROME DE GUILLAIN BARRE. Revista de Posgrado de la Via Cátedra de Medicina. N° 168 – Abril 2007 pag 15-18.

  2. González-Suárez I, Sanz-Gallego I,Rodríguez de Rivera F and Arpa J. Guillain-Barré Syndrome: Natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurology 2013 13:95.

  3. Lestayo-O’Farrill Z and Hernández-Cáceres J. Análisis del comportamiento del síndrome de Guillain-Barré. Consensos y discrepancias REV NEUROL 2008; 46 (4): 230-237.

  4. Mendoza-Hernández D, Blancas Galicia L, Gutiérrez Hernández J. Síndrome de Guillain-Barré. Instituto Nacional de Pediatría. Vol. 19, Núm. 2, Mayo-Agosto 2010 pág 56-63.

  5. Nafissi1 S et al. The Role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre Syndrome. Acta Medica Iranica, Vol. 51, No. 6 (2013) pág 372 – 376.

  6. Pascual S. Síndrome de Guillain- Barré Protocolos Diagnóstico Terapeúticos de la AEP: Neurología Pediátrica. Sevicio de Neurología Pediátrica. Hospital Infantil Universitario La Paz, Madrid. 2008. Pag 82-88.

  7. Perez Poveda J. Síndrome de Güillain Barré (SGB) Actualización. Acta Neurol Colomb Vol. 22 No. 2 Junio 2006 Pág 201-208.

  8. Puga Torres M and Padrón Sánchez M. SÍNDROME DE GUILLAIN BARRÉ. Rev Cubana Med Milit 2003;32(2):137-42.

  9. Stowe J, Andrews N, Wise L, and Miller E. Investigation of the Temporal Association of Guillain- Barre ́ Syndrome With Influenza Vaccine and Influenza like Illness Using the United Kingdom General Practice Research Database. Am J Epidemiol 2009;169:382–388.

  10. Taboada R, González G, García A. et al. Protocolo diagnóstico y terapéutico del síndrome de Guillain-Barré . Arch Pediatr Urug 2008; 79(1) pág 58-62.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2014;71